Literature DB >> 30224376

Glycoprotein nmb Is Exposed on the Surface of Dormant Breast Cancer Cells and Induces Stem Cell-like Properties.

Chen Chen1,2, Yukari Okita3,4, Yukihide Watanabe1, Fumie Abe5, Muhammad Ali Fikry1, Yumu Ichikawa1, Hiroyuki Suzuki1, Akira Shibuya5, Mitsuyasu Kato1,4.   

Abstract

Glycoprotein nmb (GPNMB) is a type I transmembrane protein that contributes to the initiation and malignant progression of breast cancer through induction of epithelial-mesenchymal transition (EMT). Although it is known that EMT is associated with not only cancer invasion but also acquisition of cancer stem cell (CSC) properties, the function of GPNMB in this acquisition of CSC properties has yet to be elucidated. To address this issue, we utilized a three-dimensional (3D) sphere culture method to examine the correlation between GPNMB and CSC properties in breast cancer cells. Three-dimensional sphere cultures induced higher expression of CSC genes and EMT-inducing transcription factor (EMT-TF) genes than the 2D monolayer cultures. Three-dimensional culture also induced cell surface expression of GPNMB on limited numbers of cells in the spheres, whereas the 2D cultures did not. Therefore, we isolated cell surface-GPNMBhigh and -GPNMBlow cells from the spheres. Cell surface-GPNMBhigh cells expressed high levels of CSC genes and EMT-TF genes, had significantly higher sphere-forming frequencies than the cell surface-GPNMBlow cells, and showed no detectable levels of proliferation marker genes. Similar results were obtained from transplanted breast tumors. Furthermore, wild-type GPNMB, but not mutant GPNMB (YF), which lacks tumorigenic activity, induced CSC-like properties in breast epithelial cells. These findings suggest that GPNMB is exposed on the surface of dormant breast cancer cells and its activity contributes to the acquisition of stem cell-like properties.Significance: These findings suggest that cell surface expression of GPNMB could serve as a marker and promising therapeutic target of breast cancer cells with stem cell-like properties. Cancer Res; 78(22); 6424-35. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30224376     DOI: 10.1158/0008-5472.CAN-18-0599

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

2.  GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.

Authors:  Gordana Maric; Matthew G Annis; Patricia A MacDonald; Caterina Russo; Dru Perkins; Doris R Siwak; Gordon B Mills; Peter M Siegel
Journal:  Oncogene       Date:  2019-03-26       Impact factor: 9.867

3.  GPNMB overexpression is associated with extensive bone metastasis and poor prognosis in renal cell carcinoma.

Authors:  Jian-Po Zhai; Zhen-Hua Liu; Hai-Dong Wang; Guang-Lin Huang; Li-Bo Man
Journal:  Oncol Lett       Date:  2021-12-01       Impact factor: 2.967

Review 4.  GPNMB: a potent inducer of immunosuppression in cancer.

Authors:  Anna-Maria Lazaratos; Matthew G Annis; Peter M Siegel
Journal:  Oncogene       Date:  2022-09-01       Impact factor: 8.756

5.  The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33.

Authors:  M Liguori; E Digifico; A Vacchini; R Avigni; F S Colombo; E M Borroni; F M Farina; S Milanesi; A Castagna; L Mannarino; I Craparotta; S Marchini; E Erba; N Panini; M Tamborini; V Rimoldi; P Allavena; C Belgiovine
Journal:  Cell Mol Immunol       Date:  2020-07-29       Impact factor: 11.530

6.  HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.

Authors:  Marco Biondini; Alex Kiepas; Leeanna El-Houjeiri; Matthew G Annis; Brian E Hsu; Anne-Marie Fortier; Geneviève Morin; José A Martina; Isabelle Sirois; Adriana Aguilar-Mahecha; Tina Gruosso; Shawn McGuirk; April A N Rose; Unal M Tokat; Radia M Johnson; Ozgur Sahin; Eric Bareke; Julie St-Pierre; Morag Park; Mark Basik; Jacek Majewski; Rosa Puertollano; Arnim Pause; Sidong Huang; Tibor Keler; Peter M Siegel
Journal:  Oncogene       Date:  2022-02-02       Impact factor: 8.756

7.  Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.

Authors:  Hao-Fan Wang; Sha-Sha Wang; Min Zheng; Lu-Ling Dai; Ke Wang; Xiao-Lei Gao; Ming-Xin Cao; Xiang-Hua Yu; Xin Pang; Mei Zhang; Jing-Biao Wu; Jia-Shun Wu; Xiao Yang; Ya-Jie Tang; Yu Chen; Ya-Ling Tang; Xin-Hua Liang
Journal:  Cell Prolif       Date:  2019-04-03       Impact factor: 6.831

8.  Role of the kringle-like domain in glycoprotein NMB for its tumorigenic potential.

Authors:  Rudy Xie; Yukari Okita; Yumu Ichikawa; Muhammad Ali Fikry; Kim Tuyen Huynh Dam; Sophie Thi PhuongDung Tran; Mitsuyasu Kato
Journal:  Cancer Sci       Date:  2019-06-26       Impact factor: 6.716

9.  Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer.

Authors:  Yu-Hsiang Huang; Pei-Yi Chu; Ji-Lin Chen; Chun-Teng Huang; Chi-Cheng Huang; Yi-Fang Tsai; Yu-Ling Wang; Pei-Ju Lien; Ling-Ming Tseng; Chun-Yu Liu
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

Review 10.  Macrophages and cancer stem cells: a malevolent alliance.

Authors:  Paola Allavena; Elisabeth Digifico; Cristina Belgiovine
Journal:  Mol Med       Date:  2021-09-28       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.